COARAVEN 150/12.5 MG BOX OF 30

Treatment of essential hypertension in adults. BIVAL, a fixed-dose combination, is indicated for patients whose blood pressure is not adequately controlled by valsartan or hydrochlorothiazide monotherapy.

Category: Cardio-Metabolic

Description
Reviews (0)

Description

Specialty	COARAVEN
Dosage	12.5 mg, 150 mg
Form	Film-coated tablet
Presentation	B/30
Primary Packaging	Blister
Specification	white opaque PVC/PVDC/Alu
INN	HYDROCHLOROTHIAZIDE, IRBESARTAN
VEIC Classification	Essential
Therapeutic Class	CARDIOVASCULAR SYSTEM
Subclass	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Laboratory	PHILADELPHIA PHARMA
Table	A
Shelf Life	24 (months)
Generic/Brand	Generic
Marketing Authorization	9353043
Authorization Date	2014-03-14
Range	Cardio-Metabolic Range